Indication
Heavy menstrual bleeding associated with uterine leiomyoma
Heavy menstrual bleeding associated with uterine leiomyoma is a gynecologic condition characterized by excessive, prolonged, or disruptive uterine blood loss during menstruation secondary to benign monoclonal smooth muscle tumors (fibroids) within the myometrium. Read more about Heavy menstrual bleeding associated with uterine leiomyoma
4 drugs 4 manufacturers
Drugs that treat it
Common Heavy menstrual bleeding associated with uterine leiomyoma therapies.
MYFEMBREE (relugolix/estradiol/norethindrone acetate)
MYFEMBREE (relugolix/estradiol/norethindrone acetate)
MYFEMBREE (relugolix/estradiol/norethindrone acetate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHeavy menstrual bleeding associated with uterine leiomyoma is a gynecologic condition characterized by excessive, prolonged, or disruptive uterine blood loss during menstruation secondary to benign monoclonal smooth muscle tumors (fibroids) within the myometrium.
Primarily affecting premenopausal women, it stems from structural and vascular alterations, including expansion of the endometrial surface area, distortion of the uterine cavity, abnormal myometrial contractility, and dysregulated endometrial angiogenesis and venous drainage.
Clinically, affected patients experience abnormally heavy menstrual flow, often defined as blood loss exceeding 80 mL per cycle or requiring frequent sanitary product changes, which frequently leads to chronic iron-deficiency anemia, pelvic pressure, and substantial fatigue.
- nih.gov
Heavy menstrual bleeding associated with uterine leiomyoma is a gynecologic condition characterized by excessive, prolonged, or disruptive uterine blood loss during menstruation secondary to benign monoclonal smooth muscle tumors (fibroids) within the myometrium Primarily affecting premenopausal women, it stems from structural and vascular alterations, including expansion of the endometrial surface area, distortion of the uterine cavity, abnormal myometrial contractility, and dysregulated endome...
- nih.gov
Heavy menstrual bleeding associated with uterine leiomyoma is a gynecologic condition characterized by excessive, prolonged, or disruptive uterine blood loss during menstruation secondary to benign monoclonal smooth muscle tumors (fibroids) within the myometrium
- nih.gov
Heavy menstrual bleeding associated with uterine leiomyoma is a gynecologic condition characterized by excessive, prolonged, or disruptive uterine blood loss during menstruation secondary to benign monoclonal smooth muscle tumors (fibroids) within the myometrium Primarily affecting premenopausal women, it stems from structural and vascular alterations, including expansion of the endometrial surface area, distortion of the uterine cavity, abnormal myometrial contractility, and dysregulated endome...
- prnewswire.com
Primarily affecting premenopausal women, it stems from structural and vascular alterations, including expansion of the endometrial surface area, distortion of the uterine cavity, abnormal myometrial contractility, and dysregulated endometrial angiogenesis and venous drainage Clinically, affected patients experience abnormally heavy menstrual flow, often defined as blood loss exceeding 80 mL per cycle or requiring frequent sanitary product changes, which frequently leads to chronic iron-deficienc...
Personalize your experience
Follow Heavy menstrual bleeding associated with uterine leiomyoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.